Cambridge VIP举办的第 24 届
Medtech MVP Venture & Partnering Conference
Medtech MVP Venture & Partnering 会议
Investing in Medtech's Future through Insight and Innovation Sharing
通过分享见解和创新来投资医疗技术的未来
2025年6月16日 - 17日
备受瞩目的第 24 届年度 MedTech MVP Venture & Partnering 大会，将再次汇聚业界最具影响力的MedTech 创新者、投资家与高管。这场峰会将提供开放坦诚的小组讨论、炉边对话、开放论坛以及丰富的交流机会，深入探讨资金募集、退出策略、监管指导、临床试验设计，以及最新医疗设备技术的发展前景等即时的课题。透过多元且经验丰富的业界领袖提供的深刻见解与实务性强的互动交流，MedTech MVP 将为与会者带来实用可行的策略，并助您建立推动创新的关键人脉。
本届大会将聚焦以下关键议题── 新政府政策下的中小企业宏观经济环境、新兴技术竞赛与企业展示、资金募集、并购（M&A）与IPO（首次公开募股）之间的选择与比较、神经刺激技术的进步、软体与硬体的融合发展趋势、高效临床试验设计策略、AI/Gen AI（生成式 AI）在 MedTech 组织中的应用、最新监管指导方针、由患者亲述的革命性医疗设备体验等。这场特别盛会将汇聚MedTech 领域的顶尖专家，透过思想交流与高品质的人际交流，携手推动产业发展。
Monday, June 16
Registration Open
Organizer's Welcome Remarks
Successfully Scaling and Commercializing a New Medtech Product
Successfully scaling a MedTech innovation requires strategic growth, regulatory expertise, and strong industry partnerships. This panel brings together experts to discuss key commercialization challenges, from securing investment to navigating FDA approval and accelerating market entry. Gain actionable insights to bring your medical device to market and drive success.
Avio Medtech Pitch Contest
Frank Jaskulke, Vice President, Sales & Business Development, Avio Medtech
Join us for the Avio Medtech Pitch Contest, where the top finalists will present their innovative solutions to a panel of expert judges in a tightly scheduled showdown. Experience back-to-back pitches followed by engaging Q&A sessions, leading up to the highly anticipated announcement of the winner. Don't miss this electrifying finale, filled with groundbreaking ideas and insights into the future of medical technology.
Transition to Breakout Discussions
BREAKOUT DISCUSSIONS
When Reimbursement Talks, People Listen: Optimizing Success and Avoiding Common RoadblocksReimbursement is the key factor in commercialization success. We will focus on the keys to optimizing successful reimbursement strategies and how to avoid common roadblocks that can slow adoption and concern investors.
Breakout Discussion (Opportunity Available)
Networking Welcome Reception
Close of Day
Tuesday, June 17
Registration and Morning Coffee
Organizer's Welcome Remarks
Healthcare Investments and Exits-Q1’25 Update and 2025 Outlook
Innovator Award Introduction
Late-Stage Investor Panel: What’s the Current Pulse on IPOs and M&A?
David Lewis, Managing Partner, Gilmartin Capital
As market dynamics shift, late-stage investors are reevaluating IPO and M&A strategies. This panel brings together industry experts to discuss the current investment landscape, key trends in public offerings, and evolving acquisition opportunities. Gain insights into what investors are looking for, how market conditions impact exit strategies, and what it takes to navigate today’s funding climate successfully.
Networking Coffee Break (Sponsorship Opportunity Available)
BREAKOUT DISCUSSIONS
Breakout DiscussionEvidence Development Challenges Posed by FDA and PayersThis session will focus on key differences in how FDA and payers evaluate the performance of medical technologies through their unique lenses. For emerging technologies in particular, widespread payer coverage routinely lags product approval. Tailoring a comprehensive evidence plan to address the needs of both stakeholders can help shorten this gap.
Breakout DiscussionLessons Learned and Future Advice for Medtech IPO NavigationLearn about the important considerations to follow from an expert panel across public and private medtech as they navigated/navigate/will navigate the world of successful public capital raising. Join Annie Wernig from J.P. Morgan's Healthcare Investment Bank, Kevin Hykes, President and CEO of CVRx, Mike Blue, CEO of Histosonics, and Mike Kujak, President and CEO of Francis Medical as they discuss this important topic.
Breakout Discussion (Opportunity Available)
Transition to General Session
PANEL DISCUSSION:Approaching Strategic Partners: Considerations for Corporate Venture CapitalJ.P. Peltier, Global Head, Healthcare, Piper Sandler
Securing the right strategic partner can accelerate growth, but engaging with corporate venture capital (CVC) requires a tailored approach. This panel explores what CVCs look for in potential investments, how to align with corporate priorities, and key considerations for structuring partnerships. Industry leaders will share strategies for navigating the CVC landscape and positioning your venture for successful collaboration.
Networking Lunch (Sponsorship Opportunity Available)
Introduction to Keynote Speaker Sponsored Presentation (Opportunity Available)
Technology Showcase: Sponsored Presentation (Opportunity Available)
Critical Insights for Entrepreneurs & Investors: How Hospitals & ASCs Evaluate New Medical Devices and Cost-Benefit Decisions
Karen Ruszkoski, Vice President, Market Access and Reimbursement, Volta
Hospitals and ambulatory surgery centers (ASCs) face increasing pressure to balance innovation with cost efficiency when evaluating new medical devices. This panel will provide critical insights into how these institutions assess new technologies, weigh clinical and financial benefits, and make purchasing decisions. Entrepreneurs and investors will gain a deeper understanding of the key factors driving adoption, helping them better position their innovations for success in today’s value-driven healthcare landscape.
BREAKOUT ROUNDTABLE DISCUSSIONS & NETWORKING REFRESHMENT BREAK
Ask the Pros: DuVal & AssociatesThis roundtable provides YOU the opportunity to direct the discussion with professionals at DuVal & Associates. Ask questions about FDA's regulatory process, overcoming submission obstacles, strategies for evidence development, and how to be appropriately aggressive yet compliant in sales and marketing practices under the Food, Drug & Cosmetic Act.
Ask the Reimbursement Experts: What Keeps You Up at Night?Reimbursement is the key factor in commercialization success. We will focus on the keys to optimizing successful reimbursement strategies and how to avoid common roadblocks that can slow adoption and concern investors.
Creative and Successful Approaches for Obtaining Reimbursement Approval
Morgan Evans, Founder & CEO, Agitated Solutions
Securing reimbursement approval is a critical step in the commercialization of new medical technologies, yet the process is complex and ever-evolving. This panel will explore innovative and proven strategies for obtaining coverage, coding, and payment from payers. Experts will share real-world insights on navigating regulatory hurdles, demonstrating value to insurers, and accelerating market adoption through effective reimbursement strategies.
The Next Generation of Neurostimulation Tech: Exploring Brain-Computer Interfaces in MedTech
Juan-Pablo Mas, Partner, Action Potential VC
Brain-computer interfaces (BCIs) are revolutionizing neurostimulation, opening new frontiers in treating neurological disorders and enhancing human capabilities. This panel brings together industry leaders, researchers, and investors to explore the latest advancements in BCI technology, its clinical applications, and the challenges of commercialization. Discover how cutting-edge innovation is shaping the future of MedTech and what it takes to bring next-generation neurostimulation devices to market.
Closing Networking Reception (Sponsorship Opportunity Available)
Close of Summit
* 活动内容有可能不事先告知作更动及调整。